US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist

1.600
-0.070-4.19%

Close Dec 2 16:00 ET

47.81MMarket Cap-804P/E (TTM)

AN2 Therapeutics Stock Forum

NVDAvsTSLA

Nov 29 12:37

$AN2 Therapeutics (ANTX.US)$ It will be risky if it cannot climb on $1.9～2.0 in the next week. But anyway, promising. Hopefully they really have some positive results

This_Guy

Nov 29 08:11

$AN2 Therapeutics (ANTX.US)$
I am in here for swing play. Chart looks good and insiders have been loading.

Trytosaveabit

Oct 17 06:03

Update

$AN2 Therapeutics (ANTX.US)$ Reuters· 1 min ago
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (Caused by Mycobacterium Tuberculosis) and Malaria

Dps

Sep 24 16:00

$AN2 Therapeutics (ANTX.US)$ any future for this or it will float between 1.04 and 1.07

Trytosaveabit

Aug 12 15:54

Hmm

$AN2 Therapeutics (ANTX.US)$ Bml Investment Partners, L.p. Reports 14.2% Passive Stake in AN2 Therapeutics as of August 9, 2024- SEC Filing

MARKET-TEST-DUMMY

Aug 11 20:49

👁

$AN2 Therapeutics (ANTX.US)$

Yolo_tdm

Aug 9 12:25

$AN2 Therapeutics (ANTX.US)$ fire sale🔥

Trytosaveabit

Jul 3 13:59

Possible upcoming catalyst? Make a note! Well ifn you want? Hehehe

$AN2 Therapeutics (ANTX.US)$ Plan to report Phase 2 topline results in August 2024 from ongoing Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC)

Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA